BMS 214662 – 1 mg

Brand:
Cayman
CAS:
195987-41-8
Storage:
-20
UN-No:
Non-Hazardous - /

BMS 214662 is a potent inhibitor of farnesyltransferase (FTase; IC50 = 1.3 nM).{53114} It is selective for FTase over geranylgeranyl transferase (GGTase; IC50 = 1,900 nM). It inhibits the growth of MEK2, A2780, and PC3 cancer cells expressing wild-type Ras (IC50s = 2.5, 0.04, and 0.15 μM, respectively), as well as HCT116, MIP, RC-165, and MIA PaCa-2 cells expressing mutant K-Ras (IC50s = 0.06, 0.3, 0.3, and 0.12 μM, respectively). BMS 214662 induces apoptosis in HCT116 cells in a concentration-dependent manner. In vivo, BMS 214662 (600 mg/kg) is curative in an HCT116 mouse xenograft model. It also reduces tumor growth in Calu-1, HT-29, EJ-1, and MIA PaCa-2 mouse xenograft models.  

 

Available on backorder

SKU: 28713 - 1 mg Category:

Description

A potent FTase inhibitor (IC50 = 1.3 nM); selective for FTase over GGTase (IC50 = 1,900 nM); inhibits the growth of MEK2, A2780, and PC3 cancer cells expressing wild-type Ras (IC50s = 2.5, 0.04, and 0.15 μM, respectively), as well as HCT116, MIP, RC-165, and MIA PaCa-2 cells expressing mutant K-Ras (IC50s = 0.06, 0.3, 0.3, and 0.12 μM, respectively); induces apoptosis in HCT116 cells; curative in an HCT116 mouse xenograft model at 600 mg/kg; reduces tumor growth in Calu-1, HT-29, EJ-1, and MIA PaCa-2 mouse xenograft models


Formal name: (3R)-2,3,4,5-tetrahydro-1-(1H-imidazol-5-ylmethyl)-3-(phenylmethyl)-4-(2-thienylsulfonyl)-1H-1,4-benzodiazepine-7-carbonitrile

Synonyms: 

Molecular weight: 489.6

CAS: 195987-41-8

Purity: ≥98%

Formulation: A solid